Anna Jarmolowicz

Anna Jarmolowicz

Auto-generated profile, based on publicly available information

Anna Jarmolowicz

Murdoch Children's Research Institute, Parkville, Victoria, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ETErin Tutty
Erin Tutty
DADavid J. Amor
David J. Amor
AJAnna Jarmolowicz
Anna Jarmolowicz
KPKate Paton
Kate Paton
DLDownie Lilian
Downie Lilian

26 September 2024 in Journal of Speech, Language, and Hearing Research
Verified
Journal Article
Closed access
MLMariana L. Lauretta
Mariana L. Lauretta
AJAnna Jarmolowicz
Anna Jarmolowicz
DADavid Amor
David Amor
SBStephanie Best
Stephanie Best
Angela MorganAngela Morgan
Angela Morgan
Purpose: Advancements in genetic testing and analysis have allowed improved identification of the genetic basis of childhood apraxia of speech, a rare speech presentation. This study aimed to understand speech-language pathologists' (SLPs') consideration of incorporation of genetics in clinical practice using a theory-informed qualitative approach. Method: Semistructured interviews were conducted with 12 pediatric SLPs using a behavior change theory (Theoretical Domains Framework [TDF]) within a case study describing a child with complex co-occurring features, including childhood apraxia of speech. Interviews focused on three stages of the patient journey (prereferral, referral, and postreferral). Interviews were analyzed to identify barriers and enablers to considering incorporation of genetics in current clinical practice. Barriers and enablers were grouped and mapped onto a contextually relevant TDF-coded analysis framework. Results: Barriers were identified across several TDF domains, through all stages of the patient journey. Lack of confidence, relevance, and level of experience were most common prereferral, and connection to and awareness of genetics services and contextual factors were barriers in the referral stage. Perception of professional role, knowledge, and beliefs about effects on families were barriers postreferral. Associated enablers were also identified, including seeing value in genetic diagnosis, support from other health care professionals, supervision, and relationships with genetics services. Conclusions: Results of this qualitative study highlight barriers and enablers to incorporating genetics into speech-language pathology clinical practice. These findings will assist in the development of theory-informed implementation strategies to support SLPs into the future. Supplemental Material: https://doi.org/10.23641/asha.24112800

5 February 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
AJAnna I. Jarmolowicz
Anna I. Jarmolowicz
EBEmma K. Baker
Emma K. Baker
EBEssra Bartlett
Essra Bartlett
DFDavid Francis
David Francis
LLLing Ling
Ling Ling
DGDavid E. Godler
David E. Godler